✦ LIBER ✦

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer

✍ Scribed by E. L. Mayer; A. H. Partridge; L. N. Harris; R. S. Gelman; S. T. Schumer; H. J. Burstein; E. P. Winer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

22 ADHERENCE TO AND PERSISTENCE WITH AN

✍ E. Mazzoni; P. Fedele; L. Orlando; A. Marino; M. D'Amico; F. Sponziello; A. Nacc 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Metronomic oral combination chemotherapy

✍ Shintaro Takao; Kaori Tane; Kouichi Hirokaga; Youko Maekawa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

472 A phase II trial of oral combination

✍ M. Hirata; S. Takao; Y. Okamoto; S. Yamashita; Y. Kawaguchi; M. Takami; H. Furus 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Phase II study of an all-oral combinatio

✍ Franco Nolè; D. Crivellari; R. Mattioli; G. Pinotti; P. Foa; E. Verri; R. Fouger 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 311 KB

Phase II study of gefitinib in combinati

✍ Ciardiello, F; Troiani, T; Caputo, F; De Laurentiis, M; Tortora, G; Palmieri, G; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

PO66 ALL-ORAL COMBINATION CHEMOTHERAPY W

✍ Suzuki, Masahiko 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB